Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SMART Anti-VEGF: Began Phase I trial

PDLI licensed exclusive North American rights to SMART Anti-VEGF from Toagosei

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE